0001203311-19-000042.txt : 20190830
0001203311-19-000042.hdr.sgml : 20190830
20190830163600
ACCESSION NUMBER: 0001203311-19-000042
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190828
FILED AS OF DATE: 20190830
DATE AS OF CHANGE: 20190830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIMPSON TODD E
CENTRAL INDEX KEY: 0001216477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 191069927
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2019-08-28
0
0001060736
SEATTLE GENETICS INC /WA
SGEN
0001216477
SIMPSON TODD E
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Financial Officer
Common Stock
2019-08-28
4
S
0
5909
73.2144
D
153371
D
Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
By: /s/ Jean Liu For: Todd E. Simpson
2019-08-30